Senate Panel OKs Bill Targeting Tribes' Drug Patent Buys

Law360 (June 27, 2019, 7:18 PM EDT) -- The Senate Judiciary Committee on Thursday cleared a bill targeting the sale of drug patents to Native American tribes to avoid patent review, against opposition from Democrats who say it's too broad and was obviated by a Federal Circuit decision last year.

Republicans pushed through the bill — one of four that the committee marked up related to drug prices, most of them gaining wide support — amid debate over whether a statute is needed to keep drug companies from transferring patents to tribal governments, which could then claim sovereign immunity to try to head off review under the America Invents...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS